Cost-effectiveness of influenza vaccination of people aged 50–64 years in Australia: results are inconclusive

摘要

Objective: Influenza cost-effectiveness studies use models for influenza clinical evolution based on a range of assumptions. We explore the importance of these assumptions and its implications in policy decisions.